New federal guidance is expanding testing for cervical cancer with a self-collection method. Dr. Mara Gordon speaks to NPR about why this option might become popular for screening for HPV.

HealthDay News — Combining human papillomavirus (HPV) DNA testing with cytology testing at first screening resulted in fewer cases of high-grade cervical intraepithelial neoplasia (CIN) lesions and ...

The addition of human papillomavirus (HPV) DNA testing to either conventional or liquid-based cytology has previously been shown to increase detection rates of high-grade cervical intraepithelial ...

Introduction Self-sampling for cervical cancer screening is a promising strategy to improve coverage and reduce strain on ...

The U.S. Food and Drug Administration (FDA) has approved a human papillomavirus (HPV) DNA test for women 25 and older that can be used to determine whether these women should have additional ...

The College of American Pathologists recently updated its evidence-based guideline recommendations for the testing of human papillomavirus in head and neck carcinomas. Guideline co-chairs William ...

Spatial genomics to reveal an immunosuppressive tumor microenvironment after chemoradiation in head and neck cancer patients. #Surveillance cohort analysis performed at the test level; individual ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window MONTREAL – ...

A new blood test can identify cancers of the head and neck caused by the human papillomavirus (HPV) up to 10 years before symptoms appear. This is the discovery of Mass General Brigham researchers who ...